We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$9.8B
AUM Growth
-$1.96B
(-17%)
Cap. Flow
-$53.6M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
15.05%
Holding
1,967
New
854
Increased
344
Reduced
350
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$80.3M |
| 3 |
Teleflex
TFX
|
+$76.7M |
| 4 |
Accenture
ACN
|
+$74.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$140M |
| 2 |
Quest Diagnostics
DGX
|
+$97.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$94.3M |
| 4 |
Tractor Supply
TSCO
|
+$78.2M |
| 5 |
AET
Aetna Inc
AET
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Technology | 12.96% |
| 4 | Financials | 11.62% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
876
DELISTED
Greenhill & Co., Inc.
GHL
| $1.14M | 0.01% |
+46,838
| New | +$1.15M |
|
|
SMTA
877
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $1.14M | 0.01% |
+159,940
| New | +$1.62M |
|
878
Sarepta Therapeutics
SRPT
$1.66B
| $1.14M | 0.01% |
+10,406
| New | +$1.3M |
|
879
Amneal Pharmaceuticals
AMRX
$5.72B
| $1.13M | 0.01% |
+83,742
| New | +$1.51M |
|
|
INOV
880
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.13M | 0.01% |
+79,948
| New | +$911K |
|
881
Ascendis Pharma A/S
ASND
$16.7B
| $1.13M | 0.01% |
18,027
+11,789
| +189% | +$741K |
|
882
Steel Dynamics
STLD
$35.6B
| $1.13M | 0.01% |
37,526
-434,918
| -92% | -$16.4M |
|
883
Prudential
PUK
$36.5B
| $1.13M | 0.01% |
+32,804
| New | +$1.25M |
|
|
NXGN
884
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.12M | 0.01% |
+74,238
| New | +$1.27M |
|
885
Cognex
CGNX
$10.3B
| $1.12M | 0.01% |
+29,009
| New | +$1.26M |
|
886
Helix Energy Solutions
HLX
$1.46B
| $1.12M | 0.01% |
+207,519
| New | +$1.69M |
|
887
Simon Property Group
SPG
$74.5B
| $1.12M | 0.01% |
6,649
+5,076
| +323% | +$907K |
|
|
OPRA
888
Opera Ltd
OPRA
$1.65B
| $1.11M | 0.01% |
+200,202
| New | +$1.37M |
|
|
NFX
889
DELISTED
Newfield Exploration
NFX
| $1.11M | 0.01% |
75,675
-173,073
| -70% | -$3.48M |
|
|
PRAH
890
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.1M | 0.01% |
12,014
-40,632
| -77% | -$4.11M |
|
891
Allegiant Air
ALGT
$2.64B
| $1.1M | 0.01% |
+11,013
| New | +$1.31M |
|
892
Grupo Aval
AVAL
$5.67B
| $1.1M | 0.01% |
186,684
+100,207
| +116% | +$687K |
|
|
XOG
893
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $1.1M | 0.01% |
256,682
+152,831
| +147% | +$1.14M |
|
894
Atmos Energy
ATO
$29.9B
| $1.09M | 0.01% |
11,779
-8,387
| -42% | -$802K |
|
|
EXTN
895
DELISTED
Exterran Corporation
EXTN
| $1.09M | 0.01% |
61,668
-34,210
| -36% | -$767K |
|
896
Centene
CNC
$31.3B
| $1.09M | 0.01% |
+18,898
| New | +$1.27M |
|
897
SiriusXM
SIRI
$10B
| $1.09M | 0.01% |
19,067
-8,914
| -32% | -$542K |
|
|
ABMD
898
DELISTED
Abiomed Inc
ABMD
| $1.08M | 0.01% |
3,330
-40,010
| -92% | -$13.9M |
|
899
Advanced Drainage Systems
WMS
$10.9B
| $1.07M | 0.01% |
+44,185
| New | +$1.19M |
|
900
Phibro Animal Health
PAHC
$1.38B
| $1.07M | 0.01% |
+33,222
| New | +$1.25M |
|
Similar funds
Marshall Wace's Q4 2018 Portfolio in Review
As of Q4 2018, Marshall Wace held 1,967 positions worth $9.8B, down 17% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Marshall Wace's Q4 2018 filing shows 854 new, 344 increased, 350 reduced and 392 closed positions. Its largest new stake was Mastercard: 339,646 shares worth $64.1M. The largest sale was McDonald's, an estimated $140M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall Wace's largest Q4 2018 buy was Mastercard: 339,646 shares worth $64.1M.
- Marshall Wace added most to Alphabet (Google) Class A in Q4 2018, an estimated $97.9M increase.
- Marshall Wace's biggest Q4 2018 reduction was McDonald's, cutting an estimated $140M.
- Marshall Wace fully exited Aetna Inc in Q4 2018, selling an estimated $77M.
- Marshall Wace's ten largest holdings make up 15% of its $9.8B portfolio in Q4 2018.
- Marshall Wace opened 854 new positions and closed 392 in Q4 2018.
- Marshall Wace's portfolio value fell 17% quarter-over-quarter to $9.8B.
Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.